Almonty Industries (ASX:AII), a global producer of tungsten critical to US defence and technology sectors, has appointed Brian Fox, CPA, as its new CFO, effective Aug. 25. Fox will succeed outgoing ...

Synlait Milk (ASX:SM1) has released a preliminary update on its performance for the financial year ending July 31. The company expects underlying EBITDA to reach between $100 million and $110 million, ...

Bank First Corporation (NASDAQ:BFC), the holding company of Bank First, today announced it has signed an agreement and plan of merger to acquire Centre 1 Bancorp, parent company of The First National ...

Offshore wind farm installation and service company Cadeler (NYSE:CDLR) has announced the early delivery of its newest acquisition, the jack-up vessel Wind Keeper. The addition to Cadeler's fleet ...

Sanofi (NASDAQ:SNY) has finalized its acquisition of Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in systemic mastocytosis (SM) and KIT-driven disease therapies, enhancing its immunology ...

O GENIUS Act regulando stablecoins está prestes a se tornar lei após a esperada assinatura do Presidente Trump, potencialmente remodelando um mercado avaliado em cerca de US$ 1 trilhão. O projeto de ...

شین ڈونووان مور، سابق نیم پیشہ ور رگبی کھلاڑی، کو ایک جعلی کریپٹوکرنسی مائننگ اسکیم میں 40 سے زائد سرمایہ کاروں کو 900,000 ڈالر سے زیادہ دھوکہ دینے پر 30 ماہ کی وفاقی جیل کی سزا سنائی گئی۔ مور نے ...

Peak Processing Solutions, the Canadian subsidiary of Althea Group (ASX:AGH), has launched its own-brand manufactured strategy with the release of Snap Back, a premium line of THC beverages. This ...

Strategic Energy Resources (ASX:SER) has acquired 100% ownership of the advanced-stage Diamantina Copper-Gold Project in western Queensland from Anglo American Exploration (Australia). The acquisition ...

Strategic Energy Resources (ASX:SER) hat 100% der Anteile am fortgeschrittenen Diamantina Copper-Gold-Projekt in West-Queensland von Anglo American Exploration (Australien) erworben. Der Erwerb ...

McPherson's (ASX:MCP) released an update on its expected full-year results for FY25, reporting revenue from continuing operations of approximately $139 million. The result reflects a pivotal year of ...

Syntara (ASX:SNT) has initiated its AZALOX Phase 1b/2 clinical trial evaluating amsulostat in combination with 5-Azacitidine for patients with high-risk myelodysplastic neoplasms and chronic ...